by Elec23 | Jul 30, 2026 | News&events, VisMederi
A new scientific publication from VisMederi has recently been published in Influenza and Other Respiratory Viruses. The study, “Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination,” analyzed data from 3,066...
by Elec23 | Jun 19, 2026 | News&events, VisMederi
From kit design and manufacturing to biological sample management and laboratory testing, VisMederi offers a fully integrated solution for clinical trials and research programs worldwide. VisMederi, a company specialized in vaccine evaluation through advanced...
by Elec23 | Jun 18, 2026 | News&events, VisMederi
VisMederi and CEVAC, a Belgian vaccine research center comprising a Clinical Trial Unit and an Immunomonitoring Laboratory, have signed a Memorandum of Understanding (MoU) to strengthen their collaboration in vaccine clinical trials, a core area of expertise for both...
by Elec23 | May 26, 2026 | News&events, VisMederi
VisMederi and KingMylab have announced the signing of a strategic collaboration agreement aimed at strengthening testing and analytical services for vaccine and biologics clinical trials. The partnership combines KingMylab’s expertise in central laboratory...
by Elec23 | Apr 7, 2026 | News&events, VisMederi
VisMederi announces the signing of a Memorandum of Understanding with Global Clinical Central Lab, an international company specializing in clinical trial services, at the World Vaccine Congress 2026, one of the leading global events dedicated to the vaccine sector....
